Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System

Sodium-glucose cotransporters inhibitors (SGLT2-i) and GLP-1 receptor agonists (GLP1-RA) are glucose-lowering drugs that are proved to reduce the cardiovascular (CV) risk in type 2 diabetes mellitus (T2DM). In this process, the renin-angiotensin-aldosterone system (RAAS) is assumed to play a role. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Puglisi, Soraya, Rossini, Alessandro, Poli, Roberta, Dughera, Francesca, Pia, Anna, Terzolo, Massimo, Reimondo, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567993/
https://www.ncbi.nlm.nih.gov/pubmed/34745006
http://dx.doi.org/10.3389/fendo.2021.738848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567993/
https://www.ncbi.nlm.nih.gov/pubmed/34745006
http://dx.doi.org/10.3389/fendo.2021.738848

Ejemplares similares